Novartis Confirmed Plans For The 100% Spin-off Of The Sandoz Business, With Trading Of New Sandoz Group Ag Shares And Adrs To Commence On October 4, 2023
Portfolio Pulse from Benzinga Newsdesk
Novartis has confirmed plans to spin-off its Sandoz business, with trading of new Sandoz Group AG shares and ADRs to commence on October 4, 2023. The shares of Sandoz are expected to be listed on the SIX Swiss Exchange and the OTCQX.
September 25, 2023 | 9:25 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Novartis is spinning off its Sandoz business, which could potentially impact its stock price.
The spin-off of Sandoz could potentially impact Novartis' stock price. However, the direction of the impact is uncertain and depends on various factors such as investor sentiment, market conditions, and the performance of the Sandoz business post spin-off.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100